Niche lubrication Target medical device makers working with biologic formulations incompatible with silicone oil lubricants to position TriboGlide and TriboLink Si as solutions to reduce friction, protein aggregation, and dose inaccuracy in prefilled syringes, infusion systems, and insulin pumps.

Cross-disciplinary value Leverage the company’s cross-disciplinary materials science expertise to address broader lubrication and particle issues beyond silicone incompatibility, opening opportunities with drug formulation developers and device manufacturers facing material compatibility challenges.

Small team agility With a lean team, emphasize personalized technical support and rapid response for early adopters and pilot programs in pharma and medtech, highlighting flexibility in collaboration on bespoke formulation and device compatibility trials.

Early revenue focus Despite a revenue range of zero to one million, prioritize high-potential pilot customers in the pharmaceutical packaging and device space where friction reduction can demonstrate measurable improvements in syringe force, dose consistency, and product yield.

Tech-enabled credibility Highlight technology stack and regulatory-conscious features (HSTS, X-Content-Type-Options, Google presence) to reassure prospective customers about security, reliability, and digital trust when engaging in sensitive pharmaceutical packaging and device development collaborations.